All these molecular events ultimately result in disruption of the KEAP1–NRF2 interaction, leading to NRF2 stabilization and persistent activation of its downstream genes, which confer protection to cancer cells from radio/chemotherapy and boost their expansion. Here, KEAP1 is linked to cancer.